Submissions

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.

The manuscript has not been formally published previously and is not currently under consideration by another journal or publisher. Any publicly available preprint has been disclosed to the Editorial Office, with its URL or persistent identifier where available.
The manuscript file is submitted in Microsoft Word format (.doc or .docx).
DOI identifiers have been provided for references where available.
The manuscript is prepared in 12-point Times New Roman with 1.5 line spacing; italics rather than underlining are used for emphasis where appropriate; and tables, figures, charts, and illustrations are placed close to their first mention in the text.
The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.
The manuscript is scholarly in nature and is appropriate for the selected article type.
The title accurately reflects the content of the article.
The manuscript does not constitute unjustified duplication, redundant publication, or inappropriate recycling of previously published material.
The topic aligns with the aims and scope of the journal.
The manuscript is written in clear, precise, and grammatically correct British English.
The cited literature represents the current state of knowledge in the field.
Where applicable, the conclusions are logical and supported by the evidence or material presented in the manuscript.
The manuscript is structured appropriately for the selected article type.
Citations and the reference list have been prepared according to Vancouver style, with references numbered sequentially in the order in which they are first cited in the manuscript.
All graphic elements include alternative text (alt-text) where technically possible.

Author Guidelines

Manuscript Preparation

Medicine and Public Health follows the recommendations of the International Committee of Medical Journal Editors (ICMJE). Authors are encouraged to consult the current ICMJE Recommendations.

Manuscripts must be written in clear and precise British English and prepared in accordance with the journal’s requirements described below.

Submission Files and Anonymisation

Medicine and Public Health uses double-blind peer review. Authors must therefore submit author-identifying information separately from the anonymised manuscript.

The Title Page must contain:

the full title of the manuscript, concise and informative and, where possible, free of unnecessary abbreviations;
full name and surname of each Author;
affiliation of each Author, including institution and country;
ORCID iD of each Author, where available;
e-mail address of each Author;
identification and contact details of the corresponding Author;
information on Supplementary Materials, where applicable;
Author Contributions statement;
Funding statement;
Ethics Approval Statement, where applicable;
Informed Consent Statement, where applicable;
Data Availability Statement;
Declaration of Generative AI Use;
Acknowledgements, where applicable;
Conflicts of Interest statement.

The Main Manuscript File must be fully anonymised and must not contain information that directly or indirectly identifies the Authors, their institutions, or other identifying details.

Article Types

Authors must select the appropriate manuscript type during submission in OJS. The journal accepts submissions in the following sections:

Article Type	General Characteristics
Original Research Papers	Original empirical, experimental, clinical, observational, epidemiological, or analytical research. Randomised clinical trials are submitted within this section.
Review Articles	Critical, systematic, or integrative synthesis of current knowledge in a defined field.
Meta-analyses	Systematic and quantitative synthesis of evidence from multiple studies addressing a clearly defined research question.
Short Reports	Concise reports of original research findings of limited scope that remain scientifically or clinically relevant.
Case Reports	Clinically relevant descriptions of individual cases, including rare conditions, unusual presentations, novel diagnostic approaches, or unexpected therapeutic outcomes.
Drug Reports	Evidence-based reports concerning pharmacotherapy, medicinal products, effectiveness, safety, adverse drug reactions, interactions, or other clinically relevant pharmacological issues.
Commentary	Concise expert interpretation, scholarly reflection, or critical discussion of a current issue relevant to medicine, public health, healthcare policy, research, or clinical practice.
Correspondence	Concise scholarly communication concerning published material or another clearly defined scientific, medical, or public health issue within the journal’s scope.

Recommended Manuscript Structure

Original Research Papers

Original Research Papers should normally follow the IMRAD structure:

Introduction
Materials and Methods
Results
Discussion
Conclusions

Review Articles

Review Articles should normally include:

Introduction
Thematic or methodological sections
Summary or discussion of the evidence
Conclusions and, where appropriate, clinical implications

Meta-analyses

Meta-analyses should clearly describe the research question, search strategy, eligibility criteria, study selection, data extraction, assessment of study quality or risk of bias, statistical methods, results, and interpretation. Relevant reporting standards, including PRISMA, must be followed where applicable.

Short Reports

Short Reports should provide sufficient methodological information for evaluation of the findings. A concise structure based on Introduction, Materials and Methods, Results, and Discussion or Conclusions is recommended.

Case Reports

Introduction
Case Presentation
Discussion
Conclusions

Case Reports should follow the CARE guidelines and must comply with applicable informed-consent requirements.

Drug Reports

Drug Reports should be concise, scientifically balanced, supported by appropriate evidence, and free from promotional content. Applicable ethical and informed-consent requirements must be observed where individual patients or identifiable clinical information are described.

Commentary and Correspondence

Commentary and Correspondence do not require an IMRAD structure. They should be concise, focused, evidence-informed, and supported by appropriate references where necessary.

Abstracts and Keywords

Original Research Papers, Review Articles, Meta-analyses, Short Reports, Case Reports, and Drug Reports should include an abstract and keywords in English.

For Commentary and Correspondence, an abstract and keywords should be provided where required by the relevant submission section or requested by the Editorial Office.

Unless more specific requirements apply to the selected manuscript type, abstracts should generally be between 250 and 500 words and should clearly summarise the purpose of the manuscript, methods or analytical approach, main findings, and conclusions, as appropriate.

Where keywords are required, Authors should provide 3–5 keywords. Keywords should be specific, searchable, and relevant to the manuscript and should not merely repeat words used in the title.

Manuscript Length

The recommended maximum length of Original Research Papers and Case Reports is 40,000 characters including spaces.

Review Articles and Meta-analyses are not subject to a fixed character limit; however, their length should be proportionate to the scope of the work, methodology, and breadth of the literature.

Short Reports, Drug Reports, Commentary, and Correspondence should be concise and proportionate to the purpose of the selected manuscript type.

File Format and General Formatting

Manuscripts should be submitted in Microsoft Word format:

.doc
.docx

The manuscript should be prepared using:

Times New Roman, 12-point font;
1.5 line spacing;
continuous and consistent formatting throughout the document;
page numbering;
line numbering where technically possible.

Foreign terms and expressions should be written in italics where appropriate. Bold or underlined text should not be used merely for emphasis.

All abbreviations must be defined at first mention and used consistently thereafter.

Units of measurement should follow the International System of Units (SI), where applicable.

Equations must remain editable and should not be submitted solely as image files.

Tables, Figures, Charts, and Illustrations

Tables, figures, charts, photographs, and illustrations should be numbered separately and consecutively in the order in which they are first mentioned in the text.

Each table, figure, chart, or illustration must have a clear title or caption and must be referred to in the manuscript.

Tables and graphic elements should be placed close to their first mention in the manuscript.

Figures and photographs should also be provided as separate high-resolution graphic files, preferably at a resolution of at least 300 dpi, in one of the following formats:

.jpg
.png
.tif
.tiff

Titles and captions should be included in the manuscript rather than embedded directly into submitted image files.

Charts should be clear and readable. Where applicable, charts should also be supplied in an editable format.

Notes to tables should be placed directly below the relevant table. Explanatory notes relating to figures or charts should be placed with the relevant caption.

All graphic elements should include alternative text where technically possible to improve accessibility.

Reporting Standards

Where applicable, Authors should follow recognised reporting guidelines appropriate to the type of study, including:

CONSORT for randomised clinical trials;
STROBE for observational studies;
PRISMA for systematic reviews and meta-analyses;
CARE for case reports;
COREQ for qualitative research.

Current PRISMA guidance is available from the official PRISMA website.

References

References and in-text citations must be prepared according to the Vancouver style. References should be numbered sequentially in the order in which they are first mentioned in the manuscript and cited in the text using Arabic numerals in square brackets.

Recommended maximum number of references:

Original Research Papers: up to 40 references;
Case Reports: up to 15 references;
Review Articles and Meta-analyses: up to 80 references.

For Short Reports, Drug Reports, Commentary, and Correspondence, the reference list should be concise and limited to sources necessary to support the manuscript.

All references must be accurate, complete, and consistent. DOI identifiers should be included for references wherever available.

Examples:

Barczyński M, Gołkowski F, Nawrot I. The current status of intraoperative iPTH assay in surgery for primary hyperparathyroidism. Gland Surg. 2015;4:36–43. doi:10.3978/j.issn.2227-684X.2015.01.01.
Hymczak H, Gołąb A, Mendrala K, Plicner D, Darocha T, et al. Core Temperature Measurement—Principles of Correct Measurement, Problems, and Complications. Int J Environ Res Public Health. 2021;18:10606. doi:10.3390/ijerph182010606.

Vol. 4 (2026)
Published: 2026-10-12

eISSN: 2956-9443

Publisher

AFM Publishing House of the Andrzej Frycz Modrzewski Krakow University

Licence CC

Submit